Have the New Pulmonary Hypertension Drugs Changed the Game?

(MedPage Today) -- In March, we reported on back-to-back FDA approvals for two treatments in pulmonary arterial hypertension (PAH). In this report, we follow up on what has happened since.
After the FDA approved both combination macitentan/tadalafil...